BlackRock’s DarioHealth DRIO Stock Holding History

BlackRock’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Buy	37,796 +18,978	+101%	+$141K	﹤0.01%	4763
2026 Q1	$151K	Hold	18,818	–	–	﹤0.01%	4862
2025 Q4	$214K	Buy	18,818 +16,337	+658%	+$215K	﹤0.01%	4706
2025 Q3	$43K	Buy	2,481 +1	+0%	+$11	﹤0.01%	4998
2025 Q2	$33.2K	Sell	2,480 -3,190	-56%	-$44.2K	﹤0.01%	5064
2025 Q1	$69.4K	Sell	5,670 -62	-1%	-$875	﹤0.01%	4854
2024 Q4	$90.1K	Buy	5,732 +21	+0.4%	+$363	﹤0.01%	4810
2024 Q3	$128K	Buy	5,711 +430	+8%	+$8.72K	﹤0.01%	4625
2024 Q2	$126K	Sell	5,281 -221	-4%	-$6.26K	﹤0.01%	4643
2024 Q1	$168K	Sell	5,502 -129	-2%	-$4.89K	﹤0.01%	4628
2023 Q4	$194K	Buy	5,631 +236	+4%	+$8.4K	﹤0.01%	4646
2023 Q3	$354K	Sell	5,395 -149	-3%	-$10K	﹤0.01%	4518
2023 Q2	$445K	Sell	5,544 -1,815	-25%	-$138K	﹤0.01%	4512
2023 Q1	$606K	Buy	7,359 +182	+3%	+$17.9K	﹤0.01%	4490
2022 Q4	$614K	Buy	7,177 +136	+2%	+$12.2K	﹤0.01%	4557
2022 Q3	$651K	Sell	7,041 -34	-0.5%	-$3.65K	﹤0.01%	4638
2022 Q2	$869K	Sell	7,075 -32,381	-82%	-$3.8M	﹤0.01%	4593
2022 Q1	$4.61M	Sell	39,456 -1,131	-3%	-$187K	﹤0.01%	4012
2021 Q4	$10.5M	Buy	40,587 +2,918	+8%	+$887K	﹤0.01%	3642
2021 Q3	$10.3M	Buy	37,669 +858	+2%	+$248K	﹤0.01%	3659
2021 Q2	$15.7M	Buy	36,811 +36,755	+65,634%	+$14M	﹤0.01%	3435
2021 Q1	$22K	Hold	56	–	–	﹤0.01%	5020
2020 Q4	$16K	Buy	+56	New	+$14.4K	﹤0.01%	4801
2019 Q2	–	Sell	-97	Closed	-$28K	–	5023
2019 Q1	$28K	Sell	97 -7	-7%	-$2.08K	﹤0.01%	4555
2018 Q4	$33K	Buy	104 +49	+89%	+$17.6K	﹤0.01%	4527
2018 Q3	$21K	Buy	55 +3	+6%	+$1.38K	﹤0.01%	4653
2018 Q2	$27K	Buy	+52	New	+$34K	﹤0.01%	4634

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock's DRIO Position: Q2 2026 in Review

BlackRock increased its DarioHealth (DRIO) stake by 101% in Q2 2026, buying an estimated $141K and bringing the position to 37,796 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #4763.

BlackRock first reported a position in DRIO in Q2 2018 and has held it in 27 quarters since. The position peaked at $15.7M in Q2 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

BlackRock held 37,796 shares of DarioHealth worth $249K as of Q2 2026.
BlackRock bought 18,978 DarioHealth shares in Q2 2026, an estimated $141K.
DarioHealth made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4763 holding.
BlackRock first reported a position in DarioHealth in Q2 2018 and has held it in 27 quarters since.
BlackRock's DarioHealth position peaked at $15.7M in Q2 2021.
21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.